Research predicts millions could avoid heart attacks with new cholesterol drug

This study aimed to estimate how many adults in the United States might be eligible for a cholesterol-lowering drug called inclisiran. Researchers used national survey data to model the potential number of heart attacks, strokes, and other cardiovascular events that could be prevented over 10 years if eligible people received the treatment. The study did not give the drug to participants but analyzed existing health data to project its possible public health benefits.